Activity of the Janus Kinase Inhibitor Ruxolitinib in Chronic Lymphocytic Leukemia: Results of a Phase II Trial
Haematologica - Italy
doi 10.3324/haematol.2015.135418
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 27, 2016
Authors
Publisher
Ferrata Storti Foundation (Haematologica)